Results 161 to 170 of about 54,680 (203)

Enhancing the Thermostability of <i>Bacillus licheniformis</i> Alkaline Protease 2709 by Computation-Based Rational Design. [PDF]

Molecules
Yuan Y, Zhao G, Lu J, Wang L, Shi Y, Zhang J.   +5 more
europepmc   +1 more source

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab. [PDF]

JAAD Case Rep
Hiel MAJ, Diercks GFH, Bolling MC, Bremer J, Meijer JM, Horváth B.   +5 more
europepmc   +1 more source

Genomic prediction powered by multi-omics data. [PDF]

Front Genet
Montesinos-López OA, Montesinos-López A, Mosqueda-González BA, Delgado-Enciso I, Chavira-Flores M, Crossa J, Dreisigacker S, Sun J, Ortiz R.   +8 more
europepmc   +1 more source

Characterization of multiple binding sites on microtubule associated protein 2c recognized by dimeric and monomeric 14-3-3ζ. [PDF]

FEBS J
Jansen S, Narasimhan S, Cabre Fernandez P, Iľkovičová L, Kozeleková A, Králová K, Hritz J, Žídek L.   +7 more
europepmc   +1 more source

Introduction of a phenylalanine sink in fast growing cyanobacterium Synechococcus elongatus PCC 11801 leads to improved PSII efficiency, linear electron transport, and carbon fixation. [PDF]

Plant J
Deshpande A, Marsing M, Singla V, Ibrahim IM, Puthiyaveetil S, Morgan JA.   +5 more
europepmc   +1 more source

Advancing real-world evidence harmonization: lessons from the UK, EMA and global policy frameworks. [PDF]

J Comp Eff Res
Sagkriotis A.
europepmc   +1 more source

Innovation and Intellectual Property management plan and reporting M14

A comprehensive collection of instruments to assist generate the effective protection of the innovation frameworks developed by the ...
openaire   +1 more source

Short-term association between ambient air pollution and heart rate variability: results from the population-based KORA S4 and FF4 studies. [PDF]

Part Fibre Toxicol
Li Y, Breitner-Busch S, Cascio WE, Zhang S, Wolf K, Rückert-Eheberg IM, Kääb S, Schmidt G, Strom A, Peters A, Schneider A.   +10 more
europepmc   +1 more source

Editorial: Advancement of RWD/RWE utilization for enhancing drug development and benefit/risk assessment. [PDF]

Front Pharmacol
Uyama Y, Bérard A, Chan KA.
europepmc   +1 more source